<DOC>
	<DOCNO>NCT02998619</DOCNO>
	<brief_summary>Men high risk prostate cancer underwent radiotherapy prostate/seminal vesicle underwent postoperative radiotherapy include pelvic lymph node 2010 2016 analyze retrospectively . The aims estimate progression-free survival well toxicity accord CTCAE v4.03 .</brief_summary>
	<brief_title>Radiotherapy Pelvic Lymph Nodes High Risk Prostate Cancer - A Retrospective Analysis</brief_title>
	<detailed_description>Collection data retrospective analysis patient high risk prostate cancer treat radiotherapy pelvic lymph node . What influence irradiation pelvic lymph node patient high risk prostate cancer term progression free survival toxicity . How influence side effect respect gastrointestinal ( proctitis , abdominal pain , diarrhea ) genitourinary ( cystitis , urinary disorder ) toxicity ( CTCAE v4.03 )</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Men high risk prostate cancer treat radiotherapy prostate/seminal vesicle postoperative radiotherapy pelvic lymph node Kantonssptial Graubuenden , Department Radiation Oncology 2010 2016 Men prostate cancer high risk disease radiotherapy pelvic lymph node</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>